The European Medicines Agency regulatory committee concludes that there is no known tie between a new class of obesity drugs and suicide. This follows previous findings by the U.S. Food and Drug Administration and a federally funded U.S. study.
The European Medicines Agency regulatory committee announced the results of its review on Friday. It’s the latest group to conclude there’s no known tie between a new class of obesity drugs and suicide.
In January, the U.S. Food and Drug Administration said a preliminary review showed no evidence of such a link, though the agency said it could not rule out that “a small risk may exist” and that it would continue to study the issue. A federally funded U.S. study also found that people taking, the medication in Ozempic and Wegovy, had a lower risk of suicidal thoughts than those taking older medications to treat diabetes and obesity.
European Medicines Agency Obesity Drugs Suicide FDA U.S. Study Diabetes Post-Marketing Data Mounjaro Zepbound
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
2024 NHL Free Agency: Top 10 European UFAsThere’s no Artemi Panarin this year, but if you need depth, you’ve got options.
Read more »
EU targets Zoetis in antitrust investigation over dog medicinesExplore stories from Atlantic Canada.
Read more »
Doping-Valieva's cocktail of medicines raises concerns around supplement dangersExplore stories from Atlantic Canada.
Read more »
Mitsui and Rohto to buy $594 million Chinese medicines company Eu Yan SangExplore stories from Atlantic Canada.
Read more »
Mitsui and Rohto to buy $594 million Chinese medicines company Eu Yan SangExplore stories from Atlantic Canada.
Read more »
What is known about Kate's cancer diagnosisKate, the Princess of Wales , has disclosed that she has cancer and is undergoing chemotherapy — though in a video announcement Friday, she did not say what kind of cancer or reveal details of her treatment.
Read more »